AMLo Biosciences
No bio yet
This person is not in any offices
AMLo Biosciences
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.